U.S. Sues to Block Amgen’s $27.8 Billion Takeover of Horizon Therapeuticsnews2023-05-16T18:16:56+00:00May 16th, 2023|The New York Times|
Some Pharmacies Are Offering Unauthorized Ozempic Alternativesnews2023-05-16T09:00:20+00:00May 16th, 2023|The New York Times|
A U.S. Experiment on Single-Payer Care Just Endednews2023-05-15T09:00:24+00:00May 15th, 2023|The New York Times|
Esto se sabe sobre Opill, la nueva ‘minipíldora’ anticonceptivanews2023-05-13T09:00:31+00:00May 13th, 2023|The New York Times|
What to Know About the New Treatment for Hot Flashesnews2023-05-12T23:07:14+00:00May 12th, 2023|The New York Times|
FDA Approves New Drug to Treat Hot Flashesnews2023-05-12T20:09:58+00:00May 12th, 2023|The New York Times|
Big Pharma Is Avoiding Taxes, and Trump’s Tax Reforms Made It Worsenews2023-05-12T18:15:20+00:00May 12th, 2023|The New York Times|
Public Health Lessons Learned From the Coronavirus Pandemicnews2023-05-11T09:00:23+00:00May 11th, 2023|The New York Times|
Addiction Treatment Medicine Is Vastly Underprescribed, Especially by Race, Study Findsnews2023-05-10T21:49:51+00:00May 10th, 2023|The New York Times|
What an Over-the-Counter Birth Control Pill Could Mean for Younews2023-05-10T19:54:43+00:00May 10th, 2023|The New York Times|